Impact of obesity and android fat distribution on the progression of hepatic fibrosis in metabolic steatopathy

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Evolution of metabolic-associated fatty liver desase measured by fibroscan and biopsy in patients with morbid obesity undergoing bariatric surgery2024
2. 2Improvement of non-alcoholic steatohepatitis as measured by elastography in obese diabetic and non-diabetic patients undergoing bariatric surgery, after one-year follow-up2024
3. 3Metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a major role for transient elastography in the screening of significant liver fibrosis2024
4. 4Predicting liver fibrosis using artificial intelligence in obese patiens2024
5. 5Impact of diabetes mellitus type 2 on the prognosis of metabolic steatopathy2024